Table 2.
Arnold et al.32 |
Chien et al.6 |
Hongo et al.33 |
Grahn Kronhed et al.34 |
Liu-Ambrose et al.35 |
|
---|---|---|---|---|---|
1. Eligibility criteria specified* | Y | Y | Y | Y | Y |
2. Random subject allocation | Y | Y | Y | Y | Y |
3. Allocation was concealed | Y | Y | N | N | N |
4. Groups were similar at baseline | Y | Y | Y | Y | Y |
5. Blinding of all subjects | N | N | N | N | N |
6. Blinding of therapists administering therapy | N | N | N | N | N |
7. Blinding of assessors | Y | Y | N | Y | Y |
8. Measures obtained from more than 85% of initial subjects | N | N | Y | Y | Y |
9. All subjects received treatment or control. If not, data analyzed by “intention to treat” | Y | Y | N | Y | N |
10. Results of between-group comparisons reported for at least one key outcome | Y | Y | Y | Y | Y |
11. Provides both point measures and measures of variability for one key outcome | Y | Y | Y | Y | Y |
TOTAL SCORE: | 7/10 | 7/10 | 5/10 | 7/10 | 6/10 |
PEDro item 1 is not used to calculate the overall PEDro score.
Y=Yes; N=No.